Continuing Education

Prescribing Mobile Health Applications

March 26, 2024 Editor

Circulation: Cardiovascular Quality and Outcomes, Ahead of Print.

← Targeted Gene Deletion or Antagonism of the Prostaglandin E2 EP3 Receptor Protects Against Cardiac Injury Postmyocardial Infarction
Estimating Vitamin K Antagonist Anticoagulation Benefit in People With Atrial Fibrillation Accounting for Competing Risks: Evidence From 12 Randomized Trials →